First Horizon Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-366
Closed -$89K 2556
2022
Q3
$89K Buy
366
+1
+0.3% +$270 ﹤0.01% 646
2022
Q2
$89K Buy
365
+351
+2,507% +$94.7K ﹤0.01% 726
2022
Q1
$5K Sell
14
-252
-95% -$77.6K ﹤0.01% 1316
2021
Q4
$95K Sell
266
-4
-1% -$1.35K ﹤0.01% 695
2021
Q3
$87K Buy
270
+15
+6% +$5.08K ﹤0.01% 720
2021
Q2
$79K Hold
255
﹤0.01% 627
2021
Q1
$80K Buy
255
+17
+7% +$5.44K ﹤0.01% 574
2020
Q4
$77K Hold
238
0.01% 491
2020
Q3
$65K Hold
238
﹤0.01% 480
2020
Q2
$57K Hold
238
﹤0.01% 493
2020
Q1
$34K Hold
238
﹤0.01% 565
2019
Q4
$40K Buy
238
+53
+29% +$9.83K ﹤0.01% 629
2019
Q3
$32K Hold
185
﹤0.01% 682
2019
Q2
$48K Buy
+185
New +$49.1K ﹤0.01% 583

Other funds holding ABMD

First Horizon Advisors's ABMD Position: Q4 2022 in Review

First Horizon Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 366 shares — an estimated $89K sold.

First Horizon Advisors first reported a position in ABMD in Q2 2019 and held it in 14 quarters. The position peaked at $95K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • First Horizon Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • First Horizon Advisors sold 366 Abiomed Inc shares in Q4 2022, an estimated $89K.
  • First Horizon Advisors first reported a position in Abiomed Inc in Q2 2019 and held it in 14 quarters.
  • First Horizon Advisors's Abiomed Inc position peaked at $95K in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on First Horizon Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.